Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review-Reference-Cited by-同舟云学术

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review

Published:2017-10-25 Issue:3 Volume:47 Page:210-224
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Hoa S¹²,Troyanov Y¹²³,Fritzler MJ⁴,Targoff IN⁵,Chartrand S²⁶,Mansour AM²⁷,Rich E¹²,Boudabbouz H²⁸,Bourré-Tessier J¹²,Albert M²⁷,Goulet JR¹²,Landry M²³,Senécal JL¹²

Affiliation:

1. Division of Rheumatology, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada

2. Faculty of Medicine, University of Montreal, Montreal, QC, Canada

3. Division of Rheumatology, Sacré-Coeur Hospital, Montreal, QC, Canada

4. Faculty of Medicine and Mitogen Advanced Diagnostics Laboratory, University of Calgary, Calgary, AB, Canada

5. Department of Medicine, University of Oklahoma, Oklahoma City, OK, USA

6. Division of Rheumatology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada

7. Research Center, Sacré-Coeur Hospital Research Center, Montreal, QC, Canada

8. Division of Rheumatology, Cité-de-la-Santé Hospital, Laval, QC, Canada

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2017.1334814

Reference80 articles.

1. Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis

2. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study

3. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

4. Anti-Melanoma Differentiation-Associated Protein 5-Associated Dermatomyositis: Expanding the Clinical Spectrum

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Adolescent Case of Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis With Interstitial Lung Disease Successfully Treated by Multitarget Therapy Avoiding Cyclophosphamide: A Case Report and Literature Review;Cureus;2024-06-15

2. Anti-melanoma differentiation-associated gene 5 (anti-MDA5) positive dermatomyositis: early detection is crucial;BMJ Case Reports;2024-06

3. Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis;Modern Rheumatology Case Reports;2024-04-10

4. New therapies in anti-MDA5 antibody-positive dermatomyositis;Current Opinion in Rheumatology;2023-09-07

5. Organizing Pneumonias and Acute Interstitial Pneumonia;Orphan Lung Diseases;2023